The El Gamal family remains detained in Texas for 10 months despite a judge’s release order, raising due process concerns ...

Digital Clinical Trial Revenue -- Rose 30% over the previous three-quarter average.

Discusses BLA Resubmission for Apitegromab in Spinal Muscular Atrophy and Regulatory Progress March 31, 2026 8:00 ...

nCino, Inc. (NASDAQ:NCNO) Q4 2026 Earnings Call Transcript March 31, 2026 nCino, Inc. beats earnings expectations. Reported EPS is $0.37, expectations were $0.21. Operator: Good day, and thank you for ...

Pediatric expansion -- Plans are in place to commence a clinical trial for Papzimius in pediatric RRP in Q4 2026. Pipeline ...

Unicycive Therapeutics, Inc. (UNCY) 25th Annual Needham Virtual Healthcare Conference April 15, 2026 3:45 PM EDTCompany ParticipantsShalabh Gupta - ...

ClearSign Technologies Corporation (NASDAQ:CLIR) Q4 2025 Earnings Call Transcript April 9, 2026 ClearSign Technologies Corporation beats earnings expectations. Reported EPS is $0.01, expectations were ...

Gross margin compression noted, with gross profit as a percentage of net sales falling to 37.9% for the quarter due to a less ...

Origin Materials, Inc. (NASDAQ:ORGN) Q4 2025 Earnings Call Transcript March 27, 2026 Origin Materials, Inc. misses on earnings expectations. Reported EPS is $-38.54 EPS, expectations were $-2.1.

Amid heated exchange and polarized opinion among the Cebu City Council on the proposed accreditation of Asian College of Technology  Pit-os scholarship, Vice Mayor Tomas Osmeña questions the body’s ...

INmune Bio, Inc. (NASDAQ:INMB) Q4 2025 Earnings Call Transcript March 30, 2026 INmune Bio, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.26. Operator: Greetings, and ...

Jennifer Bernardini of PwC discusses the recently released guidance for the material assistance and prohibited foreign entity ...